Daniel M. Klein - 01 Mar 2022 Form 4 Insider Report for Physicians Realty Trust

Reporting relationship: SVP - Deputy CIO
Issuer ticker: N/A
Reported as of: 01 Mar 2022
Net transaction value: -$85,713
SEC form: 4
Accepted by SEC: 03 Mar 2022, 15:31:30 UTC
Prior SEC filing: 23 Feb 2022
Next SEC filing: 27 Feb 2023
Source filing: View source filing
Reporting owner signature: Christopher M. Bartoli, as attorney-in-fact

Key filing fact

Daniel M. Klein filed Form 4 for Physicians Realty Trust on 03 Mar 2022.

Key facts

This page summarizes Daniel M. Klein's Form 4 filing for Physicians Realty Trust.
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2022, 15:31.

Change

Previous filing in this sequence was filed on 23 Feb 2022.
Current net transaction value: -$85,713.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOC transaction

Common shares, $0.01 par value

Award

Transaction value: $0
Shares: +12,242
Change %: +15%
Price: $0.000000
Shares after: 96,143
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F1

DOC transaction

Common shares, $0.01 par value

Tax liability

Transaction value: $85,713
Shares: -5,236
Change %: -5.4%
Price: $16.37
Shares after: 90,907
Date: 01 Mar 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DOC transaction Derivative

2022 Performance Based Restricted Share Unit Grant

Award

Transaction value: $0
Shares: +18,363
Change %
Price: $0.000000
Shares after: 18,363
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common shares, $0.01 par value
Underlying amount: 18,363
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant.

Footnote F2

March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024.